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Structural basis of suppression of host translation
termination by Moloney Murine Leukemia Virus
Xuhua Tang1, Yiping Zhu2,3, Stacey L. Baker4, Matthew W. Bowler5,6, Benjamin Jieming Chen1, Chen Chen1,
J. Robert Hogg4, Stephen P. Goff2,3 & Haiwei Song1,7,8
Retroviral reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is
expressed in the form of a large Gag–Pol precursor protein by suppression of translational
termination in which the maximal efficiency of stop codon read-through depends on the
interaction between MoMLV RT and peptidyl release factor 1 (eRF1). Here, we report
the crystal structure of MoMLV RT in complex with eRF1. The MoMLV RT interacts with the
C-terminal domain of eRF1 via its RNase H domain to sterically occlude the binding of
peptidyl release factor 3 (eRF3) to eRF1. Promotion of read-through by MoMLV RNase
H prevents nonsense-mediated mRNA decay (NMD) of mRNAs. Comparison of our structure
with that of HIV RT explains why HIV RT cannot interact with eRF1. Our results provide a
mechanistic view of how MoMLVmanipulates the host translation termination machinery for
the synthesis of its own proteins.
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D
ue to limited genome encoding capacity, viruses are
reliant on the host translation system for synthesis of
their viral proteins. Various viruses have been found
to manipulate almost every step of the host translation process,
mainly through targeting cellular translation factors1. Most
retroviruses utilize translational recoding of a viral messenger
RNA (mRNA) stop codon to express the gag gene both as an
independent polyprotein (Gag) and as a fusion (Gag–Pol)
with the polyprotein encoded by the pol gene. The ratio of Gag
to Gag–Pol is delicately balanced during virus assembly and is
critical for infection2,3. Therefore, retroviruses have developed at
least two different strategies to switch between Gag and Gag–Pol
expression, both regulated by viral pseudoknots or hairpin RNA
structures4–8. In HIV, the gag and pol genes are in different
reading frames and Gag–Pol protein production requires a  1
ribosomal frameshift at the end of the gag gene. However, in
Moloney murine leukemia virus (MoMLV), these two genes are
in the same reading frame, and the suppression of the gag UAG
termination codon permits read-through to the pol gene9.
The essential replication enzyme reverse transcriptase (RT) is
expressed as part of a Gag–Pol fusion protein, accounting for
5% of unspliced retroviral RNA translation. Biochemical and
structural studies showed that the MoMLV RT displays a
monomeric architecture containing an N-terminal polymerase
domain and a C-terminal RNase H domain (Fig. 1a)10. In
contrast, the HIV RT is a heterodimer consisting of p66 and
p51 subunits11, the latter of which is derived by proteolysis of p66
and lacks the RNase H domain.
In eukaryotes, stop codon recognition is initiated by the
binding of the essential termination factor eRF1 in complex with
a guanosine triphosphate (GTP)-bound eRF3 to the ribosome.
The subsequent dissociation of eRF3 after GTP hydrolysis
and recruitment of ATP binding cassette E1 (ABCE1) to eRF1
induce peptide release and ribosomal subunit dissociation12.
Comprehensive structural studies of eRF1 and its complexes
with other termination factors have enabled an understanding
of how eRF1 coordinates the termination events via its three
distinct domains13–18, namely the N-terminal domain (eRF1-N),
M-domain (eRF1-M) and C-terminal domain (eRF1-C) (Fig. 1a).
eRF1-N (aa 1–142) contains a conserved Asn-Ile-Lys-Ser (NIKS)
motif and has an essential role in stop codon recognition13. eRF1-M
(aa 143–276) mimics the transfer RNA (tRNA) acceptor stem and
harbours a universal GGQ tip to stretch toward the CCA end of the
peptidyl tRNA for triggering peptide release13,17. eRF1-C (aa 277–
437) functions to recruit other termination factors such as eRF3
when forming the pre-termination complex13,14,16.
Previously, we showed that MoMLV utilized its RT to interact
with host eRF1, thereby promoting stop codon read-through to
make Gag–Pol19. However, the molecular events underlying
this mechanism remain undefined. In this study, we determine
the crystal structure of MoMLV RT in complex with the
full-length mouse eRF1. Our structure shows that the MoMLV
RT interacts with the C-terminal domain of eRF1 via its RNase H
domain. Structure-guided functional assays suggest that MoMLV
RT suppresses translation termination by outcompeting eRF3
for binding to eRF1. We also show that MoMLV RNase H
promotes stop codon read-through, which in turn prevents
nonsense-mediated mRNA decay (NMD). Altogether, these
results reveal the structural basis of host translation termination
suppression by MoMLV.
Results
Structural determination. We solved the crystal structure of
MoMLV RT (aa 24–671) in complex with the full-length mouse
eRF1 at a resolution of 4.0 Å (for simplicity designated as
MoMLV RT/eRF1) (Fig. 1b). MoMLV RT contains an N-terminal
polymerase domain and C-terminal RNase H domain connected
by a flexible linker, which is not visible in the electron
density map and is assumed to be disordered. Structural
comparison of the RT polymerase domain in our structure with
that in a MoMLV RT/DNA complex20 and a Xenotropic murine
leukemia virus-related virus (XMRV) RT/RNA/DNA ternary
complex10, reveals that the binding of eRF1 did not cause a
significant conformational change in MoMLV RT’s polymerase
domain (Supplementary Fig. 1a). The catalytic residues (D524,
E562, D583 and D653) of RNase H are distant from the bound
eRF1 (Supplementary Fig. 1b). The RNase H activity assays
further confirmed that eRF1 binding does not affect the RNase H
activity (Supplementary Fig. 1c, upper panel). These findings are
consistent with our previous data that the MoMLV RT–eRF1
interaction does not affect RT’s activities19.
The MoMLV RT–eRF1 interaction is mediated via the contacts
of the RNase H domain of MoMLV RT with the C-terminal
domain of eRF1. To verify this interaction, we also determined
the crystal structure of the isolated RNase H domain of MoMLV
























Figure 1 | Structure of the MoMLV RT/eRF1 complex. (a) Schematic
representation of the domain organization of eRF1 and MoMLV RT.
Domains N, M, and C of eRF1 are coloured in pink, lightblue and green,
respectively. MoMLV RT polymerase domain is coloured in grey and RNase
H domain in yellow. (b) A ribbon diagram of the MoMLV RT/eRF1 complex.
The colouring scheme is as in a. The helix a2 of RNase H domain is
highlighted in red. (c) The RNase H/eRF1-C complex structure. The
secondary structure elements of RNase H domain are labelled.
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As the RNase H/eRF1-C interface is identical with that observed
in the MoMLV RT/eRF1 complex, subsequent analysis
concerning the RT–eRF1 interaction only refers to the RNase
H/eRF1-C structure.
Interaction of MoMLV RT with eRF1. The interaction of the
RNase H domain of MoMLV RT with eRF1-C buries a total
solvent accessible surface area of 1173Å2. The RNase H domain
mainly uses its helix a2 to interact with eRF1-C through
predominantly hydrophobic contacts (Fig. 2a). Residues Phe588,
Ala589, Ile593 and the methylene group of Arg585 in helix a2 of
the RNase H domain form a hydrophobic patch that interacts
with the hydrophobic residues of eRF1-C, including Phe291
and Ile294 in helix a8, Tyr301 and Phe303 in the loop region
connecting a8-a9 and Phe406 in loop a11-b11 (numbering as
previously described16). In addition to these predominant
hydrophobic interactions, Arg585 of the RNase H domain
forms a salt bridge with Asp307 of eRF1-C, Gln559 of RNase H
is hydrogen bonded to Asp297 of eRF1-C, and Asp511 of RNase
H forms hydrogen bonds with the carbonyl groups of Lys404 and
Gly407 in helix a11 of eRF1-C.
To examine the role of the RNase H/eRF1-C interface, we
mutated several residues and examined their effects on binding by
glutathione S-transferase (GST) pull-down assays (Fig. 2b).
Mutation of Ile294, Tyr301 or Phe406 of eRF1-C to alanine
disrupted its interaction with RNase H. Likewise, single mutations
in the isolated RNase H domain (R585A, F588A and A589K) of
MoMLV RT abolished its binding to eRF1-C (Fig. 2b). Residues
Ile294, Tyr301, Phe406 of eRF1-C and Phe588 of RNase H are the
key components of the hydrophobic RNase H/eRF1-C interface.
Single Ala mutations of these residues disrupted the RNase
H/eRF1-C interaction. Mutation of Arg585 to Ala would abolish
its salt bridge interaction with Asp307, while substitution of
Ala589 by a lysine would place a charged residue inside the
hydrophobic interface, thereby destabilizing the RNase H/eRF1-C
interaction. In contrast, single Ala substitutions of Asp511,
Gln559 and Ile593 of RNase H and Phe291, Asp297 and Phe303
of eRF1 had no effect on the RNase H/eRF1-C interaction.
Residues Asp511, Ile593 and Qln559 of RNase H, and Phe291
and Asp297 of eRF1 are located at the edge of the main interface
and would not be predicted to contribute significantly to the
RNase H/eRF1-C interaction, and therefore it is not surprising
that mutations of these residues had no effect on the interaction.
Phe303 of eRF1 is situated in the middle of the interface and
appears to be a key hydrophobic residue. One plausible
explanation for the F303A mutant of eRF1 lacking the RNase
H binding defect is that the side chain of Arg585 could rotate and
place its methylene group in a position to compensate for the loss
of the phenol group of F303A mutant.
We further examined the binding thermodynamics of
wild-type (WT) RNase H and its variants to eRF1 by isothermal
titration calorimetry (ITC). WT RNase H binds to eRF1 with an
equilibrium dissociation constant (Kd) of B4.18 mM. The RNase
H mutant F588A showed B10-fold reduced binding to eRF1,
whereas the binding of R585A or A589K to eRF1 was abrogated
(Supplementary Fig. 2a–d). These data indicate that helix a2 of
the RNase H domain in MoMLV RT harbouring these residues is
critical for the RT–eRF1 interaction.
We note that earlier mutational studies found that mutation
G525E led to a strong disruption of RT–eRF1 binding as
assessed in a yeast two-hybrid assay19. Gly525 is far from the
RT–eRF1 interface and is located in the interior of the RNase
H domain. Its substitution by a glutamate acid places a
negatively charged residue with a long side chain inside the
hydrophobic core of the RNase H domain, therefore destabilizing
the fold of RNase H. Thus, we suggest this mutation acts
indirectly.
The interaction of polymerase domain of RT with eRF1 by GST
pull-down assay was only detectable in low salt condition in the
previous study19. Thus, the crystallization buffer conditions in
this study may prevent the polymerase domain of RT from
interacting with eRF1. Intriguingly, we observe an interface
between the RT polymerase domain and eRF1 within the crystal
lattice in our MoMLV RT/eRF1 structure, but only between
symmetry-related molecules. We postulate that this observation
may only be due to the crystal packing, because the electron
density of this interface is not well defined, indicating a certain
degree of disorder in this area.
The RT–eRF1 interaction enhances read-through. To determine
the effect of the MoMLV RT–eRF1 interaction on translational
read-through, we introduced the RT mutations into the MoMLV
provirus and examined the expression levels of the Gag precursor
protein and capsid protein (CA) in virion lysates. The read-
through efficiency is evaluated here by examination of the CA/
Gag ratio, as the processing of Gag precursor protein to CA
protein is mediated by PR protease, which depends on read-
through for its expression. Compared with the WT virions, those
with mutations affecting eRF1 binding (R585A, F588A or A589K)
showed dramatically increased ratios of Gag precursor to mature
CA protein, indicating that a large fraction of the Gag precursor
proteins remained unprocessed (Fig. 3a). Although we cannot
rule out other mechanisms for the effects of the RT mutations, the
results are consistent with a reduced expression of read-through-
dependent PR protease present in the Gag–Pol precursor. The
viruses were then used to infect Rat2 cells to detect their ability to
spread. Although WT viruses rapidly spread in the cultures, all
mutants were replication defective (Fig. 3b). This finding is
consistent with the notion that the interaction with eRF1 is

























































Figure 2 | Interaction of MoMLV RT with eRF1. (a) Interface between the
RNase H domain of MoMLV RT and eRF1-C. Residues involved in the
interaction are shown as sticks and labelled. (b) GST pull-down assay. GST
tagged WT MoMLV RNase H and its mutants on beads were used to bind
His-tagged eRF1-C and its variants.
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Figure 3 | Non-interacting RT mutants showing reduced read-through are replication defective. (a) The provirus carrying mutants that are unable to
bind eRF1 show reduced read-through efficiency. The proviral DNA were used to transform 293T cells and the purified virions were analyzed by western
blot. The virion produced by WT DNA contained high levels of capsid (CA, B30 kDa), while mutants showed poor Gag (B65KDa) cleavage as a
consequence of low read-through. (b) Non-interacting RTmutants are replication defective. Release of spreading virus was detected on the indicated day
post infection. (c) HEK 293T cells were transfected with WT pNCS-3Myc-ProD27S or pNCS-3Myc-ProD27S bearing indicated mutations. Forty-eight hour
after transfection, the viruses in the supernatant were collected and purified by ultra-centrifuge through the 25% sucrose cushion. The virus pellets were
re-suspended in protein loading buffer, resolved in SDS–PAGE, and visualized by western blot using c-Myc antibody (9E10; sc-40, Santa Cruz; 1:1000
dilution). Noted that the Gag protein has a molecular mass of B70 kDa as carrying the 3Myc tag.
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effect on their RNase H activities (Supplementary Fig. 1c, lower
panel). To further examine the role of the RT–eRF1 interaction in
read-through, selected mutations (R585A, F588A or A589K) were
introduced into an MoMLV provirus in which the protease cat-
alytic site was mutated (ProD27S). In this context, the uncleaved
Gag–Pol precursor with WT RT was readily detected in virion
particles, while the Gag–Pol protein with triple mutations
(R585A/F588A/A589K) was undetectable. The A589K mutation
significantly reduced Gag–Pol levels, while the R585A or F588A
mutations had no effect on Gag–Pol levels (Fig. 3c). We conclude
that A589 is the most important amino acid for RT-mediated
enhancement of read-through. These observations support the
hypothesis that the read-through-enhancing interaction of RT
with eRF1 is required for viral replication.
MoMLV RT outcompetes eRF3 for binding to eRF1. eRF1 and
eRF3 interact predominantly via their respective C-terminal
domains (eRF1-C and domain 3 of eRF3) and bind to the
ribosomal pre-termination complex as a stable eRF1/eRF3
complex for stop codon decoding15,16. Structural superposition of
MoMLV RT/eRF1 and eRF1/eRF3 complexes showed that eRF1
interacts with both MoMLV RT and eRF3 through overlapping
surface regions (Fig. 4a), suggesting that MoMLV RT and eRF3
are mutually exclusive for binding to eRF1. In support of this
structural observation, WT RNase H but not mutants defective in
eRF1 binding efficiently outcompetes eRF3 for binding eRF1
with an apparent Kd of B5.6 mM, despite eRF3 exhibiting at
least 10 times higher affinity for eRF1 than RNase H (Fig. 4b,c;
Supplementary Fig. 2e–g). These results suggest that MoMLV RT
likely suppresses translation termination by outcompeting eRF3
for binding to eRF1.
Promotion of read-through by RNase H prevents NMD. We
introduced MoMLV or HIV RNase H immediately downstream
of the MoMLV pseudoknot (MLVPK) in dual-fluorescent-protein
reporters of translational read-through (Fig. 5a). These reporters
mimic the natural context of RNase H expression, and could
either allow activity in trans (on different mRNAs following
termination and release) or in cis (at the upstream termination
codon on the same mRNA). In the latter scenario, termination
suppression activity may be enhanced by tethering of newly
synthesized RNAse H via the nascent polypeptide. This posi-
tioning of the MoMLV RNase H domain led to Btwofold more
read-through than control constructs containing mCherry alone
or the HIV RNase H and mCherry downstream of the MoMLV
pseudoknot. Stimulation of read-through by MoMLV RNase H
was evident when using both the WT UAG stop codon and a
UAA stop codon, which reduces read-through to B2% in
controls. When moved to a position 30 of the mCherry open
reading frame (ORF), the MoMLV RNase H failed to stimulate
read-through. Because polypeptides containing C-terminal RNase
H would undergo termination and release immediately after
completion of RNase H synthesis, this finding suggests that
nascent polypeptide-mediated tethering of MoMLV RNase H to
the translating mRNA is important for optimal function (Fig. 5b).
Termination at the MoMLV gag stop codon results in an
mRNA with an effective 30UTR length of B6,000 nt, a feature
expected to make the transcript susceptible to the conserved
NMD pathway21 in the absence of a protective mechanism.
As previous observations show that induction of read-through
by the MoMLV pseudoknot can potently inhibit NMD of
reporter transcripts22, we investigated the ability of MoMLV
RNase H to augment this activity in pulse-chase decay assays of
tetracycline-regulated dual-fluorescent-protein reporters. Because
degradation by NMD is strongly 30UTR length-dependent, we
used either HIV RNase H or NanoLuc luciferase (Nluc) to
equalize 30UTR length among the constructs used. Read-through
stimulated by the WT MoMLV pseudoknot (UAG) was sufficient
to fully stabilize mRNAs with the extended mCherry-Nluc
30UTR, likely due to efficient displacement of the NMD key
effector Upf1 from the 30UTR by elongating ribosomes22 (half-life
calculated from best-fit line¼ 519min, 95% confidence of
interval (CI)¼ 423–670min). Therefore, to test a potential role
for the RNase H domain in contributing to NMD inhibition,
we used the impaired UAA MoMLV pseudoknot variant,
which promoted partial rescue of mRNAs containing Nluc
or HIV RNase H 30UTR extensions (Nluc: best-fit¼ 286min,
95% CI¼ 256–322min; HIV RNase H: best-fit¼ 296min, 95%
CI¼ 251–360min). Consistent with the read-through data above,
the presence of the MoMLV RNase H dramatically increased
RNA stability, resulting in a half-life of B530min (95%
CI¼ 457–653min). This half-life is similar to that exhibited by
mRNAs containing the UAG pseudoknot and Nluc, consistent
with a model in which promotion of read-through by MoMLV
RNase H in turn prevents NMD (Fig. 5c).
Discussion
Translation termination and ribosome recycling are two critical
processes in protein biosynthesis. During translation termination, a
stop codon in the ribosomal A site is decoded by eRF1 delivered by
eRF3 in the form of an eRF1/eRF3/GTP ternary complex. After
GTP is hydrolyzed, eRF3 dissociates from the ribosome, and
ABCE1 binds to the eRF1-bound ribosome to stimulate peptide
release and subsequent ribosomal subunit dissociation23,24.
Structural analysis showed that eRF1 uses its C-terminal domain
to interact with both eRF3 and ABCE1 (refs 13,16). Our structural
and functional studies of the MoMLV RT/eRF1 complex showed
that MoMLV RT likely suppresses stop codon read-through via
outcompeting eRF3 binding to eRF1. Since the same surface of
eRF1 is used for binding both eRF3 and ABCE1, MoMLV RT
would be predicted to compete with ABCE1 for binding to eRF1,
therefore inhibiting peptide release and possibly ribosomal subunit
dissociation as well. In this scenario, the interval between eRF3
GTP hydrolysis/dissociation and ABCE1 binding would give
MoMLV RT a window of time to interact with and inhibit eRF1.
Retroviruses appear to have evolved multiple mechanisms to
protect their mRNAs from NMD. Recent data show that a
cis-acting RNA stability element immediately downstream of
gag in unspliced Rous sarcoma virus (RSV) RNA recruits
polypyrimidine tract binding protein 1 to protect its long 30UTR
from NMD25. In deltaretrovirus human T-lymphotropic virus
type 1, it was observed that the viral protein Tax inhibits mRNA
degradation via interacting with INT6 and preventing the
association of INT6 with Upf1 (ref. 26). A possible alternative
retroviral mechanism for NMD escape was suggested by
findings that insertion of the read-through-promoting MLVPK
sequence into NMD reporter transcripts antagonizes Upf1
recruitment and subsequent mRNA decay22. In addition to
promoting stability by enhancing translational read-through,
MoMLV RNase H may have a more direct role in protecting viral
mRNAs from decay. Upf1 interacts with the C-terminal domain
of eRF1 and the GTPase domain of eRF3 to trigger NMD27,28.
Our structure shows that MoMLV RT interacts with eRF1 to
occlude eRF3 and suppress termination. Therefore, the MoMLV
RT–eRF1 interaction may prevent the recruitment of Upf1 to
the terminating ribosome by disrupting the Upf1–eRF1
interaction, thereby allowing the gag-pol mRNA to bypass
degradation by NMD.
The RNase H domain is structurally well conserved among
retroviral RTs and exhibits similar substrate recognition activity
(Fig. 6a,b). Sequence alignment of helix a2 in RNase H domains
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from various retroviruses reveals that the three eRF1-interacting
amino acids of MoMLV RT—R585, F588 and A589—are
identical in gammaretroviruses, which utilize read-through for
Gag–Pol production but are highly variable in other genera of
retroviruses that utilize frameshifting (Fig. 6c; Supplementary
Fig. 3a). The residues equivalent to both R585 and F588 are
replaced by an alanine in alpharetrovirus RSV and betaretrovirus
Mason pfizer monkey virus (MPMV), while the residues
equivalent to A589 are substituted by a lysine in RSV, a histidine
in MPMV and a glutamate in spumaretrovirus human foamy
virus. This observation and our ITC data described above suggest
that R585, F588 and A589 in MoMLV RT are structural
determinants for its interaction with eRF1, and alterations of
these key residues in other genera of retroviruses would render
their RTs being unable to bind to eRF1.
The conformational flexibility of the retroviral RNase H
domain, which represents the major difference between the
monomeric and dimeric retroviral RTs10, may also account for
the species-dependent specificity of the MoMLV RT–eRF1
interaction. The RNase H domain in monomeric RTs is highly
flexible and disordered in previously solved monomeric RT
structures including MoMLV RT in complex with dsDNA20 and
XMRV RT in complex with a DNA/RNA hybrid10. Our MoMLV
RT/eRF1 structure reveals the full-length monomeric RT
architecture for the first time, made possible by the fact that
the orientation of the RNase H domain is fixed upon binding
eRF1. Structural superposition of MoMLV and HIV RTs based on
the polymerase domain showed that MoMLV RNase H swings
92 to a completely different position, accompanied by a
moderate movement of thumb and connection subdomains
a
b c
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Figure 4 | The RNase H domain of MoMLV RT outcompetes eRF3 for binding to eRF1. (a) Superposition of the RNase H/eRF1-C complex with the
eRF1/eRF3 complex (PDB accession code: 3E1Y) at eRF1-C domain. The overlapping interface suggests that MoMLV RTand eRF3 are mutually exclusive for
binding to eRF1. eRF3 domain 3 is shown in cartoon (blue) covered with grey transparent surface. eRF3 domain 2 and eRF1-C domain in eRF1/eRF3 complex
are not displayed for clarity. (b,c) Representative ITC titrations of WT RNase H and mutant A589K to the eRF1/eRF3 complex. The upper panels show the
binding isotherms and the lower panels show the integrated heat for each injection fitted to a single-site model.
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(Fig. 6d). This movement is conferred by a 32 amino acid linker
region between the connection and RNase H domains of MoMLV
RT, whereas this loop region is not found in HIV RT and is
relatively short in other genera of retroviruses (Supplementary
Fig. 3b). Moreover, the RNase H domain of HIV RT is spatially
locked by the p51 subunit, and consequently its helix a2 is not
accessible for binding eRF1 (Fig. 6d; Supplementary Fig. 3c).
The presence of a long flexible linker that is essential for MoMLV
viral replication29, together with the lack of a p51-like subunit to
restrict RNase H movement, accounts for the wide-range of
RNase H motion observed in MoMLV RT. Taken together, these
data suggest that translation termination suppression mediated by
the RT–eRF1 interaction appears to represent a unique tactic used
by gammaretroviruses, typified by MoMLV.
The expression levels of Gag and Gag–Pol in most retroviruses
are delicately balanced to maintain at a ratio close to 20:1, which
is critical for infection2. The production of Gag–Pol results from a
translational recoding event, which involves either ribosomal
frameshifting or read-through of the gag stop codon30. In
MoMLV, although a RNA pseudoknot structure downstream of
the gag stop codon directs the read-through process6,31, the
maximal efficiency of read-through also requires the MoMLV
RT/eRF1 interaction19. The binding of eRF1 by MoMLV RT
upregulates read-through, thereby creating a positive feedback
loop to drive the synthesis of more Gag–Pol. The effect in the
context of the full-length viral mRNA may be strongest in cis,
with the nascent Gag–Pol precursor reaching back to interact
with eRF1, thereby enhancing read-through for the next ribosome
coming along (Supplementary Fig. 4). The outcompetition of
eRF3 by MoMLV RT for eRF1 binding would be expected to
require a high local concentration of MoMLV RT, as the binding
affinity of MoMLV RT to eRF1 is much weaker than that of eRF3
to eRF1. The ultimate determinants of the frequency of
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Figure 5 | MoMLV RNase H enhances stop codon read-through and
stabilizes mRNAs. (a) Schematic of tet-regulated reporter mRNAs used in
read-through and mRNA decay assays. The indicated RNase H variants
were inserted downstream of the MLVPK, in-frame with the GFP and
mCherry ORFs. The red dot represents the stop codon. (b) Translational
read-through assays using dual-fluorescent-protein reporters containing
the indicated MLVPK and RNase H variants. The ratio of mCherry:GFP from
each experimental construct was normalized to that arising from a
sequence-matched control lacking a stop codon between GFP and mCherry.
Error bars indicate s.d. (n¼ 7; ****Po0.0001; ***Po0.001 in one-way
ANOVA with Sidak’s multiple comparisons test). (c) Semi-log plot of levels
of the indicated tet-regulated mRNAs throughout pulse-chase mRNA decay
assays. Best-fit lines calculated by the least-squares method are indicated;
error bars denote s.d. (n¼4; P values were calculated using ANCOVA



























Figure 6 | Structural explanation of why HIV RT cannot interact with
eRF1. (a) Cartoon representation of the RNase H domain of MoMLV RT.
(b) The RNase H domain of HIV RT, which is coloured in cyan with its helix
a2 highlighted in purple. (c) Sequence alignment of the helix a2 from
various genera of retroviruses. MoMLV, XMRV and PERV (Porcine
endogenous retrovirus) belong to gammaretrovirus. HIV-1 and EIVA
(Equine infectious anaemia) are lentivirus. BLV (Bovine leukemia virus),
HFV (Human foamy virus), MPMV (Mason pfizer monkey virus) and RSV
(Rous sarcoma virus) belong to deltaretrovirus, spumaretrovirus,
betaretrovirus and alpharetrovirus respectively. (d) Superposition of
MoMLV RT and HIV RT p66 (PDB accession code: 1HYS) at their
polymerase domains. HIV RTp66 except RNase H domain and p51 subunits
are shown as surfaces coloured in cyan and salmon, respectively.
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interactions involving the binding of the RNA pseudoknot, RT,
eRF1/eRF3, mRNA as well as ABCE1 to the terminating ribosome
in such a feedback loop.
Methods
Protein expression and purification. Full-length mouse eRF1 (sharing 100%
sequence identity with human eRF1) and its N-, M- and C-domains, as well as
MoMLV RT lacking its N-terminal region (aa 24–671), an isolated RT polymerase
domain (aa 24–499) and an isolated RT RNase H domain (aa 500–671) were
cloned into the vector pGEX-6P-1 (GE Healthcare) and expressed as GST fusion
proteins in E. coli BL21-CodonPlus(DE3)-RIL strain (Agilent Technologies). The
mutants were created using QuikChange II XL Site-Directed Mutagenesis Kit
(Agilent Technologies). WT and mutant proteins were purified by Glutathione
Sepharose 4B resin, followed by PreScission protease cleavage, ion exchange and gel
filtration chromatography (GE Healthcare). To make the RT/eRF1 complex, equal
molarity of RT and eRF1 were mixed in gel filtration buffer (20mM HEPES pH 7.5,
150mM NaCl and 2mM DTT) and loaded into the Hiload Superdex 200
column (GE Healthcare). The fractions containing the complex were pooled and
concentrated to around 10mgml 1. The RNase H/eRF1-C complex was
similarly prepared but purified instead using the Hiload superdex 75 column
(GE healthcare) equilibrated with gel filtration buffer (20mM HEPES pH 7.5,
150mM NaCl and 5mM DTT) and concentrated to 65mgml 1.
Crystallization and structure determination. The MoMLV RT/eRF1 complex
crystals were obtained in the crystallization condition containing 0.02M
magnesium chloride, 0.1M HEPES pH 7.5, 20% polyacrylic acid sodium salt 5100
by the hanging-drop vapour diffusion method at 4 C. The crystals were
cyroprotected by the mother liquor supplemented with 25% (v/v) ethylene glycol
before flash freezing in liquid nitrogen. The RNase H/eRF1-C complex crystals
were grown by mixing 1 ml protein with 1 ml reservoir solution containing 0.1M
Tris pH 8.5 and 18% ammonium dihydrogen phosphate at 15 C and 25% (v/v)
glycerol supplemented reservoir condition was used as cryo-protectant. The X-ray
diffraction data of the MoMLV RT/eRF1 complex crystals were collected on the
beamline ID-23-1 (ESRF, Grenoble, France) and beamline PX-I (SLS, PSI,
Switzerland). The diffraction images of the RNase H/eRF1-C complex crystals were
collected on beamline I02 (DLS, UK and the beamline BL13B1 (NSRRC, Taiwan)).
The data were processed by the XDS programme32. Both structures were solved by
molecular replacement with PHASER33. The models were further manually built
using COOT34, refined by CNS35 using the DEN methodology36, Phenix37 and
REFMAC5 (ref. 38). Structure validation was performed using PROCHECK39. The
statistics for the diffraction data and structure refinement are listed in Table 1.
Stereo image of a representative part of electron density map around the RNase H
helix a2 is shown in Supplementary Fig. 5.
In vitro binding experiments. Overall, 50 ml beads bound with WT GST-tagged
MoMLV RNase H and its mutants were incubated with 1 mg of purified His-tagged
eRF1-C protein at 4 C for 1 h in buffer containing 20mM HEPES pH 7.5 and
150mM NaCl. The beads were washed several times and the bound proteins were
analyzed by SDS–PAGE gel and western blotting.
Isothermal titration calorimetry. ITC measurements were performed at 22 C
using MicroCal VP-ITC (MicroCal Inc.). Protein samples were dialyzed into a buffer
containing 20mMHEPES pH 7.5, 150mMNaCl and 5mM TCEP. A sample syringe
with stirring speed of 290 r.p.m. was used to titrate the injectant protein
(220–300mM) into a cell containing 13–20mM protein. The titration comprised 29
injections of 10ml each, separated by 240 s equilibration time. The datasets were
analyzed using the Origin 7.0 program, fitted to a single-site binding model.
RNase H activity assays. RNase H activity assays were carried out as previously
described40. A RNA template (50 UCUUUUCAACGACGAAAAGA 30) was heat
annealed to a threefold molar excess of DNA primer (50 TCTTTTCGTTG 30) to
yield a RNA–DNA duplex substrate. MoMLV RNase H was incubated with
RNA–DNA duplex at 37 C in buffer containing 50mM Tris (pH 8.0), 60mM KCl,
0.1mgml 1 bovine serum albumin, 2mM dithiothreitol and 0.5mM EDTA.
Reactions were initiated by the addition of 0.5mM MnCl2 and were stopped at
10min by adding an equal volume of 100% formamide containing bromophenol
blue. RNase H cleavage products were resolved on 15% polyacrylamide—7M urea
gels and stained by GelRed (Biotium).
Virus purification and virus replication assays. WT pNCA was described pre-
viously19. Lenti-X 293T (Clontech) and Rat2 cells were maintained in DMEM
Table 1 | Diffraction data collection and refinement statistics.
MoMLV RT/eRF1 MoMLV RNase H/eRF1-C
Data collection
Resolution limit (Å) 4.0 2.8
Space group P3221 C2
Cell parameters
a/b/c (Å) 93.0/93.0/291.2 89.6/63.9/60.4
a/b/g () 90.0/90.0/120.0 90.0/96.9/90.0
Unique reflections (N) 12,901 (3,557) 8,469 (1,229)
Total reflections (N) 82,665 (23,699) 57,658 (8,342)
Mean (I/s) 6.9 (2.5) 23.6 (3.2)
Completeness (%) 99.7 (99.3) 99.9 (99.9)
CC(1/2) 0.99 (0.86) 1.0 (0.88)
Rmerge* 0.10 (0.70) 0.06 (0.62)
Redundancy 6.4 (6.7) 6.8 (6.8)
Refinement statistics
Data range (Å) 96.7–4.0 (4.1–4.0) 60.0–2.8 (2.9–2.8)
Used reflections (N) 12,209 (849) 8,037 (614)
Protein residues 1,004 260




z (%) 29.5 28.0
r.m.s. deviation
Bond length (Å) 0.010 0.012
Bond angles () 1.31 1.58
Ramachandran plot (% residues)
Allowed 97.1 99.6
Generously allowed 1.5 0.4
Disallowed 1.4 0










|Fc|, where Fo denotes the observed structure factor amplitude, and Fc denotes the structure factor amplitude calculated from the model.zRfree is as for Rwork, but calculated with 5% of randomly chosen reflections omitted from the refinement.
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medium supplemented with 10% FBS. For virus packaging, Lenti-X 293 T cells in
60mm dishes were transfected with 5 mg plasmids using Lipofectamine LTX
with Plus Reagent (Life Technologies). Two days after transfection, cells were lysed
for western blot to analyze the expression of MoMLV proteins. The supernatant of
transfected cells was filtered through 0.45mm membrane and further
ultra-centrifuged through the 25% sucrose cushion at 35,000 r.p.m. for 2 h to purify
the virus. For replication assay, Rat2 cells in 6-well plate were infected with 100ml
supernatants from MoMLV provirus DNA (WT or mutants) transfected 293 T cells
for 3 h. The supernatants were taken out everyday after infection to detect the
reverse transcriptase activities. pNCS-3Myc-ProD27S was constructed from
pNCS-3Myc by mutating the aspartate in the protease catalytic site to serine to
eliminate the protease activity. pNCS-3Myc was provided by Dr Eran Bacharach
(Tel Aviv University, Tel Aviv, Israel), which contains three myc tag repeats in the
p12 domain of Gag as described previously41.
Read-through and mRNA decay assays. To create vectors for read-through and
mRNA decay assays, the EGFP and mCherry were cloned into the tetracycline-
regulated pcTET2 bwtb vector42, replacing all b-globin sequence. The hybrid
intron from the pCI vector (Promega) was amplified by PCR and inserted into the
HindIII site of the resulting vector to create pcTET2iFP. The indicated MLVPK
variants were inserted between the GFP and mCherry ORFs, placing the stop
codon in-frame. Control constructs in which the stop codon was replaced by a
CAG codon were generated for each sequence variant. Codon-optimized RNase H
domains from HIV-1 or MoMLV containing the catalytic D524N mutation or
Nano luciferase (Promega) were cloned in-frame downstream of MLVPK or
mCherry as indicated.
For dual-fluorescent-protein read-through assays, 293 Tet-off cells (Clontech)
were maintained in DMEM supplemented with 10% FBS, and transfected with
Turbofect (ThermoFisher) according to the manufacturer’s instructions. Cells were
collected 48 h post transfection in 1 passive lysis buffer (Promega), and
fluorescence was measured on a Tecan Infinite F200 plate reader. Read-through
efficiency was determined by normalizing the ratio of GFP:mCherry fluorescence
from the experimental construct to GFP:mCherry fluorescence from a sequence-
matched control plasmid lacking a termination codon between GFP and mCherry,
as previously described43.
mRNA decay assays were performed using Hela Tet-off cells (Clontech) as
previously described22 with minor modifications. Cells were split to 60mM plates
at a density of 5 105 cells per plate and Turbofect (ThermoFisher) was used for
transfection with 800 ng of the indicated experimental vector, 200 ng of pcDNA
GFP TP22 as a co-transfection control, and 500 ng pcDNA 3.1 empty vector, in the
presence of 2 ngml 1 doxycycline. Following a 24-h incubation, cells were
transferred to 12-well plates. The next day, cells were washed into DMEMþ 10%
tetracycline-free FBS (Clontech) for 4 h. Transcription was halted with 1 mgml 1
doxycycline, and timepoints were collected in Trizol (Life Technologies) after
30min and at 3 h intervals thereafter. Northern blotting was performed as
described using hexamer-labelled DNA probes against the full GFP sequence22,
detected using a Storm 865 phosphorimager (GE Healthcare), and quantified on
ImageStudio software (Li-Cor). Half-lives were determined from the best-fit line to
semi-log plots of relative RNA abundances over time, and statistical significance
was calculated by the ANCOVA analysis using Prism software (Graphpad).
Data availability. The atomic coordinates and structural factors for MoMLV
RT/eRF1 and MoMLV RNase H/eRF1-C have been deposited with the Protein
Data Bank under accession codes 5DMQ and 5DMR, respectively. All other data
are available from the corresponding authors on reasonable request.
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